Anthem Inc.
http://www.antheminc.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Anthem Inc.
ICER Will Explore Link Between Reasonable Drug Pricing And ‘Fair’ US Formulary Policies
Study will examine prior authorization and other access restrictions at 15 of the largest US commercial payers for a group of 27 drugs.
ICER Study On Coverage 'Fairness' Could Inform Manufacturer Pricing vs Benefit Design Debate
Study will look at prior authorization, step therapy and required medication switching for drugs considered to be reasonably priced.
Express Scripts Could Negotiate Drug Rebates For 100m Lives With Prime Therapeutics Deal
Manufacturers will face the “biggest PBM ever” in price negotiations for pharmacy benefit drugs as a result of the collaboration between the two pharmacy benefit managers.
Randomized Study Objectives Should Drive Choice Of Real-World Data Sources, Experts Say
Start with the trial’s primary objective and then figure out which RWD sources could help inform that outcome, experts say at Duke-Margolis meeting; however, design and underlying objectives of Novo Nordisk’s real-world use of trial of Ozempic have the FDA’s Robert Temple suggesting success will be a ‘longshot.’
Company Information
- Industry
- Pharmaceuticals
- Services
- Other Names / Subsidiaries
-
- Beacon Health Options
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice